Johnson & Johnson execs to testify about COVID-19 vaccine

Drugmaker Johnson & Johnson says it will be able to provide 20 million U.S. doses of its single-shot COVID-19 vaccine by the end of March, assuming it gets the greenlight from federal regulators.